We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+11.96%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$109B
AUM Growth
+$5.89B
(+5.7%)
Cap. Flow
-$3.72B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
343
New
8
Increased
53
Reduced
229
Closed
9
Avg Time Held
5.7
years
Top 10 Avg Time Held
5
years
Top 20 Avg Time Held
5.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Splunk Inc
SPLK
|
+$164M |
| 2 |
Fidelity National Information Services
FIS
|
+$140M |
| 3 |
Intel
INTC
|
+$124M |
| 4 |
GSK
GSK
|
+$111M |
| 5 |
Mobileye
MBLY
|
+$62.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$753M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$370M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Charles Schwab
SCHW
|
+$197M |
| 5 |
Morgan Stanley
MS
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.81% |
| 2 | Technology | 27.17% |
| 3 | Industrials | 11.89% |
| 4 | Financials | 8.82% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Greif Class B
GEF.B
$4.19B
| $1.88M | ﹤0.01% |
24,000
-1,000
| -4% | -$73K |
2013 Q2
38 quarters
|
|
302
Freshworks
FRSH
$3.59B
| $1.82M | ﹤0.01% |
123,900
-155,000
| -56% | -$2.15M |
2021 Q4
4 quarters
|
|
303
Tenable Holdings
TENB
$4.1B
| $1.79M | ﹤0.01% |
47,050
+150
| +0.3% | +$5.5K |
2022 Q1
3 quarters
|
|
304
DELISTED
Hawaiian Holdings, Inc.
HA
| $1.63M | ﹤0.01% |
158,500
-23,400
| -13% | -$313K |
2014 Q2
34 quarters
|
|
305
DELISTED
Sun Country Airlines
SNCY
| $1.59M | ﹤0.01% |
100,105
+27,230
| +37% | +$478K |
2021 Q1
7 quarters
|
|
306
DELISTED
Safehold Inc.
SAFE
| $1.53M | ﹤0.01% |
53,600
| – | – |
2020 Q4
8 quarters
|
|
307
Materialise
MTLS
$461M
| $1.36M | ﹤0.01% |
155,000
-99,501
| -39% | -$985K |
2018 Q2
18 quarters
|
|
|
CALA
308
DELISTED
Calithera Biosciences, Inc
CALA
| $1.31M | ﹤0.01% |
401,080
-13,400
| -3% | -$32K |
2019 Q4
12 quarters
|
|
309
Madison Square Garden
MSGS
$9.54B
| $1.24M | ﹤0.01% |
6,773
| – | – |
2020 Q1
11 quarters
|
|
310
Snap
SNAP
$10.4B
| $1.22M | ﹤0.01% |
136,550
| – | – |
2020 Q2
10 quarters
|
|
311
Liberty Media Corporation Series A Common Stock
FWONA
$20.9B
| $1.2M | ﹤0.01% |
+23,396
| New | +$1.19M |
2022 Q4
0 quarters
|
|
312
Adaptive Biotechnologies
ADPT
$3.83B
| $1.12M | ﹤0.01% |
146,190
-4,310
| -3% | -$33.5K |
2020 Q1
11 quarters
|
|
313
Kroger
KR
$37.6B
| $1.11M | ﹤0.01% |
25,000
| – | – |
2021 Q4
4 quarters
|
|
314
DELISTED
Faro Technologies
FARO
| $1.06M | ﹤0.01% |
36,100
-13,400
| -27% | -$398K |
2013 Q2
38 quarters
|
|
315
DELISTED
Calavo Growers
CVGW
| $1.06M | ﹤0.01% |
35,900
| – | – |
2017 Q3
21 quarters
|
|
316
Frontier Group Holdings
ULCC
$1.09B
| $1.03M | ﹤0.01% |
99,900
+28,200
| +39% | +$328K |
2021 Q2
6 quarters
|
|
317
Credo Technology Group
CRDO
$31.9B
| $969K | ﹤0.01% |
72,800
+48,900
| +205% | +$649K |
2022 Q2
2 quarters
|
|
318
Bloom Energy
BE
$65.2B
| $948K | ﹤0.01% |
49,600
| – | – |
2019 Q3
13 quarters
|
|
319
Arista Networks
ANET
$223B
| $868K | ﹤0.01% |
28,600
-1,000
| -3% | -$30.8K |
2014 Q2
34 quarters
|
|
320
Arbutus Biopharma
ABUS
$836M
| $819K | ﹤0.01% |
351,500
-71,800
| -17% | -$172K |
2015 Q1
31 quarters
|
|
321
Bioceres Crop Solutions
BIOX
$17.6M
| $795K | ﹤0.01% |
66,119
-57,940
| -47% | -$752K |
2022 Q3
1 quarter
|
|
322
Marqeta
MQ
$1.95B
| $765K | ﹤0.01% |
31,300
-18,375
| -37% | -$502K |
2021 Q3
5 quarters
|
|
323
Armstrong World Industries
AWI
$7.11B
| $686K | ﹤0.01% |
10,000
| – | – |
2016 Q4
24 quarters
|
|
324
Neurocrine Biosciences
NBIX
$13.8B
| $609K | ﹤0.01% |
+5,100
| New | +$597K |
2022 Q4
0 quarters
|
|
325
Controladora Vuela Compania de Aviacion
VLRS
$676M
| $602K | ﹤0.01% |
72,000
| – | – |
2013 Q4
36 quarters
|
|
Similar funds
Primecap Management's Q4 2022 Portfolio in Review
As of Q4 2022, Primecap Management held 343 positions worth $109B, up 5.7% from $103B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $3.72B in Q4 2022, closing 9 positions and reducing 229 holdings. Its most notable exit was Abiomed Inc, an estimated $370M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Mobileye worth $72.3M.
- Primecap Management's largest Q4 2022 buy was Mobileye: 2,061,470 shares worth $72.3M.
- Primecap Management added most to Splunk Inc in Q4 2022, an estimated $164M increase.
- Primecap Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $753M.
- Primecap Management fully exited Abiomed Inc in Q4 2022, selling an estimated $370M.
- Primecap Management's ten largest holdings make up 33% of its $109B portfolio in Q4 2022.
- Primecap Management opened 8 new positions and closed 9 in Q4 2022.
- Primecap Management's portfolio value rose 5.7% quarter-over-quarter to $109B.
Based on Primecap Management's 13F filing for Q4 2022, filed 13 Feb 2023.